Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India
{{output}}
Background: Private healthcare is choice of point of care for 70% of Indians. Multidrug resistant tuberculosis (MDR-TB) treatment is costly and involves duration as long as 2 years. ... ...
